Roberta and the São Paulo team unpack ANVISA RDC 751/2022 in plain English, with case studies from medical-device, pharma, and consumer-health brands that have launched in the past 18 months.
Taevas
On-demandMedical DevicesPersonal Care & BeautyPharmaceuticalsFood & Dietary Supplements
Accelerate Your Brazil Market Entry: Legal Representative Services for Medical Devices, Pharmaceuticals & Consumer Products
Gain insights into the essential steps for successfully entering the Brazil market for medical devices, pharmaceuticals, and consumer products. Learn about the regulatory landscape, the role of a legal representative, and effective strategies to streamline the market entry process.
12 February 20251h2 time zones
Recording
Watch the full session
Free to watch in full · slides linked below
What you'll learn
Four big things you walk away with
Practical, no-fluff takeaways you can act on the same week.
ANVISA RDC 751/2022 risk classes and which apply to your portfolio
How a Brazilian legal representative differs from a distributor — and why you need both
Customs realities for medical, pharma, and consumer-health imports into Brazil
Cost and timeline benchmarks for fresh-registration vs grandfathering
Agenda
How the 60-minute session runs
Tight, well-rehearsed, and always ends on time.
- 00:00 – 03:00
Welcome and housekeeping
Introductions, attendee map, audio check.
- 03:00 – 12:00
Market context and the regulator lens
Snapshot of growth drivers, recent regulatory shifts, and what changed in the past 12 months.
- 12:00 – 30:00
Step-by-step: licence pathway walk-through
Live walk-through of the documents, dossiers, and decision points an entering brand will face.
- 30:00 – 42:00
Operational realities post-approval
Vigilance, renewals, port clearance, recall procedures, change-control.
- 42:00 – 55:00
Live Q&A
Open-floor questions answered by the speaker.
- 55:00 – 60:00
Closing and next steps
How to book a 1:1 follow-up consultation and access the slide deck.
Hosted by
Meet the speaker
Roberta Maria Rodrigues
Head of Brazil OperationsBrazil
Roberta runs Taevas' São Paulo office and is an ANVISA-listed legal representative. She has secured RDC 751/2022 registrations for over 80 international device families and authored Taevas' Brazil cosmetic notification playbook.
Connect on LinkedInRelated sessions
More from the same series
Upcoming
1h
Aug
13
2026
Brazil Pharma Annual Update — RDC 751/2022 in Practice and 2026 Pricing Realities
A São Paulo-led briefing on what it actually takes to launch and price a pharmaceutical product in Brazil today — ANVISA dossier expectations, CMED pricing pathways, post-launch SUS dynamics, and the most common rejection reasons in 2026.
4 takeaways6-step agenda2 zones
Roberta Maria Rodrigues
Head of Brazil Operations · Brazil
Pharmaceuticals
RegisterUpcoming
1h
Jul
09
2026
India's Personal Care Boom — IAR-Led Market Entry for D2C and Modern-Trade Brands
How a competent Indian Authorized Representative shortens a 14-month entry into 4–5. Channel strategy, Nykaa/Amazon onboarding, BIS compliance, ladder pricing, and Instagram-led D2C builds — all condensed into one hour.
4 takeaways6-step agenda2 zones
Ishita Singh
Director · Global Market Entry · India HQ
Personal Care & Beauty
RegisterUpcoming
45 min
Jun
11
2026
EU MDR — What's Changed in 2026 and Why It Matters for Non-EU Brands
A focused 45-minute briefing on the 2026 EU MDR amendments — extended Article 120 transitional periods, the digital UDI pilot, and how Authorised Representative obligations have shifted. Aimed at non-EU brands holding (or seeking) CE marking.
4 takeaways6-step agenda2 zones
Michael Lambell
EU Pharma Lead · United Kingdom
Medical DevicesPharmaceuticals
Register